11:31 AM EST - Kalytera Therapauetics Inc. : Announced it has applied for a $5-million grant from the Israel Innovation Authority to fund development of its portfolio of novel cannabidiol prodrugs. Kalytera Therapauetics Inc.
shares V.KALY are trading up $0.005 at $0.39.
